Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novx Systems was a medical technology company that specialized in the development of point-of-care diagnostic platforms. The company's flagship technology was a proprietary system designed to provide rapid, laboratory-quality results for immunoassays and clinical chemistry in decentralized settings. Its primary applications included drugs-of-abuse testing and infectious disease screening for clinics and physician offices. In 2007, Novx Systems was acquired by Alere (formerly Inverness Medical Innovations) to strengthen its professional diagnostics and toxicology portfolio. The acquisition allowed for the integration of Novx's automated testing capabilities into Alere's global distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novx Systems.